Oakland, CA, United States of America

Alan Ashworth

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of California. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alan Ashworth. Retrieved from https://idiyas.com/inventor/alan-ashworth-5nqkl0fs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alan Ashworth: Innovator in T-Cell-Based Immunotherapy

Introduction

Alan Ashworth is a prominent inventor based in Oakland, CA. He has made significant contributions to the field of immunotherapy, particularly in the development of gene targets for T-cell-based treatments. His work is vital in advancing cancer therapies and improving patient outcomes.

Latest Patents

Alan Ashworth holds a patent titled "Gene Targets for T-Cell-Based Immunotherapy." This patent represents a crucial step in the ongoing research and development of innovative cancer treatments. His expertise in this area has positioned him as a key figure in the scientific community.

Career Highlights

Ashworth is affiliated with the University of California, where he continues to engage in groundbreaking research. His career is marked by a commitment to enhancing the understanding of immunotherapy and its applications in treating various cancers.

Collaborations

Throughout his career, Alan has collaborated with notable colleagues, including Eric Shifrut and Julia Carnevale. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Alan Ashworth's contributions to T-cell-based immunotherapy exemplify the impact of dedicated research in the medical field. His work not only advances scientific knowledge but also holds the potential to transform cancer treatment for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…